India sulfadiazine market is expected to
grow at a steady rate during the forecast period. The India sulfadiazine market
is driven by the widespread use of the drug along with pyrimethamine for the
treatment of toxoplasmosis. Additionally, the drug is used in the treatment of
rheumatoid fever, chlamydia, among others. Furthermore, the drug is present in
the WHO’s list of essential medications. This in turn is expected to positively
influence the market growth through FY2026.
The India sulfadiazine market is
segmented based on product type, route of administration, source, form, distribution
channel, application, end user, company and region. Based on route of
administration, the market can be categorized into oral, topical and
intravenous. The oral route is expected to dominate the market since when the
drug is consumed orally the absorption takes place along the complete line of
GI tract. The intravenous
route is expected to grow significantly since this route of administration has
100% bioavailability and provides desired blood concentrations in the human
body.
The major players operating in the India
sulfadiazine market are Abbott India Ltd.,
Boehringer Ingelheim India Private Ltd., Novartis India Ltd., Emcure
Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd., Anuh Pharma Ltd., Anuja
Healthcare Ltd., Salvi Chemical Industries Ltd., Centurion Laboratories Private
Ltd., Pfizer Ltd. and others. Major companies are developing advanced
technologies, receiving approvals from regulatory bodies and launching new products
in order to stay competitive in the market. Other competitive strategies
include mergers & acquisitions, portfolio enhancement and new product
developments.
Years
considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
Objective
of the Study:
- To analyze and estimate the
market size of India sulfadiazine market from FY2016 to FY2019.
- To estimate and forecast the
market size of India sulfadiazine market from FY2020 to FY2026 and growth
rate until FY2026.
- To classify and forecast India
sulfadiazine market based on product type, route of administration, source,
form, distribution channel, application, end user, company and regional
distribution.
- To identify dominant region
or segment in the India sulfadiazine market.
- To identify drivers and
challenges for India sulfadiazine market.
- To examine competitive
developments such as expansions, new product launches, mergers &
acquisitions, etc., in India sulfadiazine market.
- To identify and analyze the
profile of leading players operating in India sulfadiazine market.
- To identify key sustainable
strategies adopted by market players in India sulfadiazine market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive
secondary research for this study. Initially, TechSci Research sourced a list
of manufacturers across the globe. Subsequently, TechSci Research conducted
primary research surveys with the identified companies. While interviewing, the
respondents were also enquired about their competitors. Through this technique,
TechSci Research could include the manufacturers which could not be identified
due to the limitations of secondary research. TechSci Research analyzed the manufacturers,
distribution channels and presence of all major players across the globe.
TechSci
Research calculated the market size of India sulfadiazine market using a bottom-up approach, wherein data for various end-user
segments was recorded and forecast for the future years. TechSci Research
sourced these values from the industry experts and company representatives and
externally validated through analyzing historical data of these product types
and applications for getting an appropriate, overall market size. Various
secondary sources such as company websites, news articles, press releases,
company annual reports, investor presentations and financial reports were also studied
by TechSci Research.
Key Target Audience:
- Sulfadiazine manufacturers/ suppliers/
distributors
- Market research and consulting firms
- Government bodies such as regulating
authorities and policy makers
- Organizations, forums and alliances related to
sulfadiazine
The study is useful in providing answers to several critical
questions that are important for the industry stakeholders such as manufacturers,
suppliers and partners, end users, etc., besides allowing them in strategizing
investments and capitalizing on market opportunities.
Report Scope:
In this report, India sulfadiazine market has
been segmented into following categories, in addition to the industry trends
which have also been detailed below:
- India Sulfadiazine Market, By Product Type:
- India Sulfadiazine Market, By Route of Administration:
- India Sulfadiazine Market, By Source:
- In-House
- Contract
Manufacturing Organizations
- India Sulfadiazine Market, By Form:
- Tablet
- Capsule
- Cream
- Injection
- Others
- India Sulfadiazine Market, By Distribution Channel:
- India Sulfadiazine Market, By Application:
- Urinary Tract
Infections
- Ear
Infections
- Meningitis
- Malaria
- Toxoplasmosis
- Others
- India Sulfadiazine Market, By End User:
- Adult
- Pediatric
(more than 2 months)
- India Sulfadiazine Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in India sulfadiazine market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and profiling of
additional market players (up to five).
India Sulfadiazine market is
an upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]